Luminescence Technology Corp. (TPEX:6729)

Market Cap	649.16M
Revenue (ttm)	112.94M
Net Income (ttm)	17.40M
Shares Out	25.16M
EPS (ttm)	0.69
PE Ratio	37.39
Forward PE	n/a
Dividend	0.95 (3.89%)
Ex-Dividend Date	Jul 24, 2025

Volume	83,442
Average Volume	47,251
Open	24.45
Previous Close	24.45
Day's Range	24.45 - 27.30
52-Week Range	16.90 - 29.30
Beta	0.53
RSI	47.05
Earnings Date	Aug 8, 2025

About Ligand Pharmaceuticals

Luminescence Technology Corp. manufactures and sells organic chemicals in North America, Europe, Asia, and Taiwan. It offers organic light emitting diode (OLED) materials, thermally activated delayed fluorescent (TADF), and small molecular and polymer solution processed OLED materials; organic photovoltaic (OPV) materials, including small molecular/oligomer, polymer, hole/electron transport, self-assembled monolayers, perovskite solar cells, and dye-sensitized solar cell materials; and organic photodiodes (OPD), and perovskite-based photodiodes...

• Industry: Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 41
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6729

Financial Performance

In 2024, Luminescence Technology's revenue was 112.94 million, an increase of 12.60% compared to the previous year's 100.30 million. Earnings were 17.40 million, a decrease of -40.63%.